West Nile Virus Vaccine
INDICATIONS: For intramuscular
vaccination of healthy horses 10 months of age or older as an aid in
the prevention of viremia caused by West Nile Virus. Efficacy was
demonstrated in horses that received two doses of the vaccine and were
challenged one year post-vaccination with West Nile Virus. The vaccine
protected 95% of the vaccinates against viremia, while 82% of the
controls were viremic.
Owners should be advised that vaccinated horses may
develop antibody to West Nile Virus, which may affect their ability to
export the animal.
DOSE: Inject one 1 mL dose
intramuscularly using aseptic technique. Administer a second 1 mL dose
3 to 6 weeks after the first dose. Revaccinate annually with one 1 mL
dose. Early revaccination may be advisable when horses are faced with
an outbreak or with other conditions which might make heavy exposure
CAUTION: Store in the dark at 2° to
7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when
first opened. In some instances, transient local reactions may occur at
the injection site. Do not vaccinate within 21 days before slaughter.
In case of anaphylactoid reaction, administer epinephrine.
Thimerosal, neomycin and polymyxin B added as preservatives.
For Veterinary Use Only
U.S. Pat. Nos. 7,153,513; 7,445,787 and patents pending
© 2000 Fort Dodge Animal Health. All Rights Reserved.
Fort Dodge Animal Health, A division of Wyeth, Fort Dodge, Iowa 50501 USA
U.S. Vet. License No. 112
12 x 1 mL syringes
10 x 10 mL
NAC No.: 10032720